Investigation for Investors in Bristol-Myers Squibb Co (NYSE:BMY) over Potential Wrongdoing Announced

San Diego, CA -- (SBWIRE) -- 08/24/2016 -- Certain directors of Bristol-Myers Squibb Co are under investigation over possible wrongdoing. The investigation was announced for current long-term investors in NYSE:BMY shares over potential breaches of fiduciary duties by certain directors at Bristol-Myers Squibb.